Access to premium content is restricted to healthcare professionals / registered members. Login with your email address to continue.
Forgot Your Password?
Follow Topic
Bookmark
New regulations mean that products with a very short shelf life, and personalised medicines such as gene therapy, can more easily be made in or near a hospital setting
22 Oct 2024
The MHRA approved two “presentations of the adapted vaccine” after they met its standards of safety, quality, and effectiveness.
11 Oct 2024
Elafibranor (Iqirvo) has been approved by the MHRA to treat adult patients with a rare type of liver disease known as primary biliary cholangitis
08 Oct 2024
Fruquintinib stops tumours making new blood vessels, which normally provide the tumour with nutrients and oxygen.
20 Sep 2024
MHRA issues new precautionary advice in wake of Scandinavian study
05 Sep 2024
The MHRA has approved generic versions of raltegravir which reduce the amount of HIV in a patient’s blood when used with other medicines.
22 Jul 2024
Migraine and antiseizure medication topiramate (Topamax) must no longer be prescribed to women and girls unless they fulfil the requirements of a Pregnancy Prevention Programme
24 Jun 2024
Mandip Sidhu, 47, of Littleover, Derby, and Nabeil Nasr, 42, of Cheadle, Greater Manchester, each received 24-month suspended sentences.
17 May 2024
MHRA says patients should be alert to behaviour and mood-related changes associated with the treatment, and seek urgent medical attention if neuropsychiatric reactions occur.
30 Apr 2024
Evotrox manufacturer went to 'unacceptable' lengths to falsify Evotrox shelf life data
18 Mar 2024
Ganaxolone (Ztalmy) treats cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder.
14 Mar 2024
Codeine linctus is to be reclassified to a prescription-only medicine due to the risk of abuse, dependency and overdose, the MHRA has announced.
20 Feb 2024
By collecting genetic samples, the Yellow Card Biobank aims to determine whether a suspected side effect was caused by a specific genetic trait.
13 Feb 2024
Updated regulatory measures are now in place to reduce the known harms from valproate.
09 Feb 2024
The MHRA, working with law enforcement partners, says it seized more than 15.5 million doses of illegally traded medicines with a street value of more than £30 million during 2023.
30 Jan 2024
Systemic fluoroquinolones must now only be prescribed when other commonly recommended antibiotics are inappropriate, the MHRA advises after safety review
23 Jan 2024
